Gog 3007, a Randomized Phase Ii (Rp2) Trial of Everolimus and Letrozole (El) or Hormonal Therapy (Medroxyprogesterone Acetate/Tamoxifen, Pt) in Women with Advanced, Persistent or Recurrent Endometrial Carcinoma (Ec): A Gog Foundation Study

AuthID
 P-00W-5NZ
7
Author(s)
Slomovitz, B
·
Filiaci, V
·
Coleman, R
·
Walker, J
·
Fleury, A
·
Holman, L
·
Document Type
Article
Year published
2018
Published
in Gynecologic Oncology, ISSN: 0090-8258
Volume: 149, Pages: 2
Indexing
Crossref®18
Google Scholar®
Publication Identifiers
Source Identifiers
ISSN: 0090-8258
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service